Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report

Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report

Abstract Background Tocilizumab is a humanized monoclonal antibody that acts as an IL-6 receptor antagonist. Intravenous tocilizumab is considered an option for children with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis. In contrast, the potential of subcutaneous drug use wit...

Full description

Bibliographic Details
Main Authors: Francesca Burlo, Cristina Tumminelli, Serena Pastore, Gabriele Stocco, Debora Curci, Marianna Lucafò, Alberto Tommasini, Andrea Taddio
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Uveitis
Inflammation
Biological therapies
Serum
Arthritis
Children
Online Access:https://doi.org/10.1186/s12969-023-00883-y

Internet

https://doi.org/10.1186/s12969-023-00883-y

Similar Items